Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Sexuality 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Prostatic Neoplasms 1Erectile Dysfunction 1

Interventions

Surveys and Questionnaires 5Radiotherapy 3Counseling 3Therapeutics 2Psychiatric Rehabilitation 2Exercise 2trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alectinib 1Vitamin E 1Vitamin D 1Uterine Myomectomy 1Testosterone Propionate 1Testosterone 1Sildenafil Citrate 1Sexual Health 1Sex Education 1Restraint, Physical 1Radiosurgery 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sexual Dysfunction, Physiological × ArginMax × Clear all
NCT00459134 2021-09-28

L-Arginine Supplements in Treating Women Who Are Cancer Survivors

Wake Forest University Health Sciences

Phase NA Completed
186 enrolled 11 charts
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡